Mehul Shah
Internal Medicine · Saint Petersburg, FLNPI 1326129214
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AstraZeneca at 29.5% of the total. Reporting peaked in 2019 at $1,233 and has fallen 89.6% since, to $128 in 2024. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 171 payments — averaging $29.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$1K
- Johnson & Johnson$701
- Lilly USA, LLC$519
- Boehringer Ingelheim$308
- Novo Nordisk$160
- plus $840 from 16 others
What the payments were for
- Food & beverage$5,081100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 31 | $1,497 |
| GSK | 36 | $1,056 |
| Johnson & Johnson | 24 | $701 |
| Lilly USA, LLC | 22 | $519 |
| Boehringer Ingelheim | 14 | $308 |
| Novo Nordisk | 8 | $160 |
| UCB, Inc. | 2 | $135 |
| Bayer | 5 | $114 |
| Amarin Pharma, Inc. | 5 | $110 |
| Novartis | 4 | $76 |
| Pfizer | 4 | $72 |
| Amgen | 3 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Indivior Inc. | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Abbott | 1 | $24 |
| Portola Pharmaceuticals, LLC | 1 | $23 |
| AbbVie | 1 | $21 |
| GE HealthCare | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,081 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 82 | $466 |
| Levothyroxine Sodium | 22 | $370 |
| Losartan Potassium | 39 | $234 |
| Lisinopril | 51 | $175 |
| Pravastatin Sodium | 12 | $150 |
| Pantoprazole Sodium | 14 | $137 |
| Metoprolol Tartrate | 16 | $116 |
| ClopidogrelClopidogrel Bisulfate | 14 | $107 |
| Alendronate Sodium | 12 | $102 |
| Amlodipine Besylate | 21 | $101 |
| Omeprazole | 22 | $94 |
| Rosuvastatin Calcium | 16 | $82 |
| Metformin Hcl | 23 | $81 |
| Tamsulosin Hcl | 13 | $78 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Saint Petersburg
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.